Table 3.

Overall and subgroup prevalence of EATING DISORDERS

	Number of studies (number of datasets)	n	Number of cases	I2 (p-value)	Prevalence (%)	95% CI	p-value
Lifetime prevalence	10 (12)	61,230	1280	98.7 (< 0.001)	(R) 0.91	0.48–1.71	–
ED(any)	4 (4)	24,732	682	98.9 (< 0.001)	(R) 1.69	0.75–3.76	< 0.001
ED(AN + BN)	4 (4)	22,852	228	97.5 (< 0.001)	(R) 0.83	0.35–1.93
ED(unknown)	1 (3)	3608	9	0.0 (0.435)	(F) 0.25	0.13–0.48
DSM-IV	8 (10)	52,088	1194	98.8 (< 0.001)	(R) 1.17	0.46–2.20	–
DSM-5	0	–	–	–	–	–
Studies conducted 1990–1999	4 (4)	17,398	147	87.5 (< 0.001)	(R) 0.91	0.59–1.31	0.005
Studies conducted 2000–2009	4 (4)	30,186	763	99.3 (< 0.001)	(R) 2.00	0.54–4.37
Studies conducted 2010–2017	2 (4)	13,646	370	98.6 (< 0.001)	(R) 0.71	0.00–3.15
Studies in Western countries	8 (8)	51,347	1258	98.5 (< 0.001)	(R) 1.89	1.03–3.01	< 0.001
Studies in Asia	2 (4)	9883	22	0 (0.623)	(F) 0.22	0.14–0.32
Males	7 (7)	21,626	241	96.7 (< 0.001)	(R) 0.74	0.24 -1.52	0.034
Females	7 (7)	24,380	869	98.8 (< 0.001)	(R) 2.58	1.06–4.74
12-month prevalence	10 (12)	61,230	489	96.9 (< 0.001)	(R) 0.43	0.18–0.78	–
ED(any)	4 (4)	24,732	290	98.0 (< 0.001)	0.72	0.15–1.71	< 0.001
ED(AN + BN)	4 (4)	22,852	80	92.8 (< 0.001)	0.34	0.11–0.69
ED(unknown)	1 (3)	3608	6	66.8 (0.049)	0.10	0.00–0.38
DSM-IV	8 (10)	52,088	448	97.4 (< 0.001)	(R) 0.41	0.13–0.83	–
DSM-5	0	–	–	–	–	–
Studies conducted 1990–1999	4 (4)	17,398	62	69.3 (0.021)	(R) 0.36	0.59–1.31	0.776
Studies conducted 2000–2009	4 (4)	30,186	308	98.7 (< 0.001)	(R) 0.68	0.54–4.37
Studies conducted 2010–2017	2 (4)	13,646	119	95.0 (< 0.001)	(R) 0.26	0.00–3.15
Studies in Western countries	8 (8)	51,347	480	96.6 (< 0.001)	(R) 0.68	0. 34–1.13	< 0.001
Studies in Asia	2 (4)	9883	9	61.0 (0.053)	(F) 0.08	0.01–0.23
Males	7 (7)	21,626	103	95.0 (< 0.001)	(R) 0.22	0.03–0.59	0.045
Females	7 (7)	24,380	330	96.7 (< 0.001)	(R) 0.93	0.37–1.74
4-week prevalence	6 (8)	27,072	61	81.4 (< 0.001)	(R) 0.20	0.09–0.36	—